Cargando…

Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma: A meta-analysis

OBJECTIVE: To define the role of adjuvant chemotherapy in the management of resectable intrahepatic cholangiocarcinoma (ICC) by performing a meta-analysis. SUMMARY BACKGROUND DATA: Oncological benefit of adjuvant chemotherapy in resectable ICC remains controversial, high-level evidence in such conte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Ka Wing, Cheung, Tan To, Leung, Brian, She, Brian Wong Hoi, Chok, Kenneth Siu Ho, Chan, Albert Chi Yan, Dai, Wing Chiu, Lo, Chung Mau
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380775/ https://www.ncbi.nlm.nih.gov/pubmed/30702559 http://dx.doi.org/10.1097/MD.0000000000014013

Ejemplares similares

The effect of wide resection margin in patients with intrahepatic cholangiocarcinoma: A single-center experience
por: Ma, Ka Wing, et al.
Publicado: (2016)

Defining the optimal bilirubin level before hepatectomy for hilar cholangiocarcinoma
por: She, Wong Hoi, et al.
Publicado: (2020)

Critical appraisal of TNM versus HKU staging system for postoperative prognostic evaluation of hepatocellular carcinoma
por: She, Wong Hoi, et al.
Publicado: (2021)

Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population
por: Ma, Ka Wing, et al.
Publicado: (2019)

Impact of small-for-size liver grafts on medium-term and long-term graft survival in living donor liver transplantation: A meta-analysis
por: Ma, Ka Wing, et al.
Publicado: (2019)

Survival outcomes of hepatocellular carcinoma resection with postoperative complications – a propensity-score-matched analysis
por: Chok, Kenneth S.H., et al.
Publicado: (2017)

Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels
por: She, Wong Hoi, et al.
Publicado: (2018)

Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors
por: Liu, Rui-qing, et al.
Publicado: (2013)

Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection
por: Li, Xiao-hui, et al.
Publicado: (2022)

Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma
por: Chun, Yun Shin, et al.
Publicado: (2017)

Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma
por: Chen, Xing, et al.
Publicado: (2022)

Survival Analysis of Re-resection Versus Radiofrequency Ablation for Intrahepatic Recurrence After Hepatectomy for Hepatocellular Carcinoma
por: Chan, Albert C. Y., et al.
Publicado: (2011)

Pneumocystis jirovecii-related spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema in a liver transplant recipient: a case report
por: She, Wong Hoi, et al.
Publicado: (2019)

Performance of Dual-tracer PET-CT for Staging Post–Liver Transplant Hepatocellular Carcinoma Recurrence
por: Au, Kin-Pan, et al.
Publicado: (2021)

Complex Liver Resections for Intrahepatic Cholangiocarcinoma
por: Reese, Tim, et al.
Publicado: (2021)

Textbook oncologic outcomes and regionalization among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma
por: Munir, Muhammad M., et al.
Publicado: (2022)

Liver Transplantation for Hepatitis B Virus-related Hepatocellular Carcinoma in Hong Kong
por: Ma, Ka Wing, et al.
Publicado: (2018)

Molecular Subtypes and Precision Oncology in Intrahepatic Cholangiocarcinoma
por: Czauderna, Carolin, et al.
Publicado: (2021)

Precision oncology for intrahepatic cholangiocarcinoma in clinical practice
por: Tomczak, Aurelie, et al.
Publicado: (2022)

Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End‐Stage Liver Disease and Hepatorenal Syndrome
por: Wong, Tiffany Cho‐Lam, et al.
Publicado: (2021)

Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study
por: Wang, Lei, et al.
Publicado: (2020)

Resection of intrahepatic cholangiocarcinoma in elderly patients – is it reasonable?
por: Bartsch, Fabian, et al.
Publicado: (2019)

Vascular Resection for Intrahepatic Cholangiocarcinoma: Current Considerations
por: Alikhanov, Ruslan, et al.
Publicado: (2021)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Adjuvant transarterial chemoembolization following radical resection for intrahepatic cholangiocarcinoma: A multi-center retrospective study
por: Wang, Lei, et al.
Publicado: (2020)

Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma: A Focus on Oncological Outcomes
por: Ratti, Francesca, et al.
Publicado: (2021)

Latent Risk Intrahepatic Cholangiocarcinoma Susceptible to Adjuvant Treatment After Resection: A Clinical Deep Learning Approach
por: Jeong, Seogsong, et al.
Publicado: (2020)

The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis
por: Ke, Qiao, et al.
Publicado: (2020)

Impact of Tumour Biology on Outcomes of Radical Therapy for Hepatocellular Carcinoma Oligo-Recurrence after Liver Transplantation
por: Au, Kin-Pan, et al.
Publicado: (2022)

Importance of surgical margin in the outcomes of hepatocholangiocarcinoma
por: Ma, Ka Wing, et al.
Publicado: (2017)

DWI-based radiomic signature: potential role for individualized adjuvant chemotherapy in intrahepatic cholangiocarcinoma after partial hepatectomy
por: Yang, Yang, et al.
Publicado: (2022)

The role of microRNAs in intrahepatic cholangiocarcinoma
por: Li, Zheng, et al.
Publicado: (2016)

Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma
por: Cheng, Chi-Tung, et al.
Publicado: (2015)

Current Management of Intrahepatic Cholangiocarcinoma: From Resection to Palliative Treatments
por: Bartolini, Ilenia, et al.
Publicado: (2020)

Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma
por: Nickkholgh, A., et al.
Publicado: (2019)

Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma
por: Buettner, Stefan, et al.
Publicado: (2019)

The Role of Surgical Resection and Liver Transplantation for the Treatment of Intrahepatic Cholangiocarcinoma
por: Panayotova, Guergana, et al.
Publicado: (2021)

Recurrence after Curative Resection for Intrahepatic Cholangiocarcinoma: How to Predict the Chance of Repeat Hepatectomy?
por: Langella, Serena, et al.
Publicado: (2021)

Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors
por: Wong, Jeffrey Sum Lung, et al.
Publicado: (2021)

Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?
por: Garajová, Ingrid, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_coqc4qt5moamc0uj0v1soo7c00